148 related articles for article (PubMed ID: 19897347)
1. Myricetin and quercetin are naturally occurring co-substrates of cyclooxygenases in vivo.
Bai HW; Zhu BT
Prostaglandins Leukot Essent Fatty Acids; 2010 Jan; 82(1):45-50. PubMed ID: 19897347
[TBL] [Abstract][Full Text] [Related]
2. The Physiologic Activity and Mechanism of Quercetin-Like Natural Plant Flavonoids.
Chen W; Wang S; Wu Y; Shen X; Xu S; Guo Z; Zhang R; Xing D
Curr Pharm Biotechnol; 2020; 21(8):654-658. PubMed ID: 32048963
[TBL] [Abstract][Full Text] [Related]
3. Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids.
Bai HW; Zhu BT
J Lipid Res; 2008 Dec; 49(12):2557-70. PubMed ID: 18660529
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for certain naturally occurring bioflavonoids to function as reducing co-substrates of cyclooxygenase I and II.
Wang P; Bai HW; Zhu BT
PLoS One; 2010 Aug; 5(8):e12316. PubMed ID: 20808785
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of COX-2 and iNOS by amentoflavone and quercetin in A549 human lung adenocarcinoma cell line.
Banerjee T; Van der Vliet A; Ziboh VA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(5-6):485-92. PubMed ID: 12144868
[TBL] [Abstract][Full Text] [Related]
6. Antiaggregatory effects of flavonoids in vivo and their influence on lipoxygenase and cyclooxygenase in vitro.
Swies J; Robak J; Dabrowski L; Duniec Z; Michalska Z; Gryglewski RJ
Pol J Pharmacol Pharm; 1984; 36(5):455-63. PubMed ID: 6442773
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages.
Chen YC; Shen SC; Lee WR; Hou WC; Yang LL; Lee TJ
J Cell Biochem; 2001; 82(4):537-48. PubMed ID: 11500931
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E(2) production.
Shen SC; Lee WR; Lin HY; Huang HC; Ko CH; Yang LL; Chen YC
Eur J Pharmacol; 2002 Jun; 446(1-3):187-94. PubMed ID: 12098601
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of prostaglandin E2 in vivo or in vitro.
Weinreb M; Kelner A; Keila S
J Endocrinol; 2002 Jul; 174(1):127-35. PubMed ID: 12098671
[TBL] [Abstract][Full Text] [Related]
10. In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E(2) extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms.
Pepicelli O; Fedele E; Bonanno G; Raiteri M; Ajmone-Cat MA; Greco A; Levi G; Minghetti L
J Neurochem; 2002 Jun; 81(5):1028-34. PubMed ID: 12065615
[TBL] [Abstract][Full Text] [Related]
11. Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry.
Weber A; Ni J; Ling KH; Acheampong A; Tang-Liu DD; Burk R; Cravatt BF; Woodward D
J Lipid Res; 2004 Apr; 45(4):757-63. PubMed ID: 14729864
[TBL] [Abstract][Full Text] [Related]
12. A structure-activity study on the influence of phenolic compounds and bioflavonoids on rat renal prostaglandin synthetase.
Baumann J; von Bruchhausen F; Wurm G
Naunyn Schmiedebergs Arch Pharmacol; 1979 May; 307(1):73-8. PubMed ID: 113685
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 in myocardium stimulation by angiotensin-II in cultured cardiac fibroblasts and role at acute myocardial infarction.
Scheuren N; Jacobs M; Ertl G; Schorb W
J Mol Cell Cardiol; 2002 Jan; 34(1):29-37. PubMed ID: 11812162
[TBL] [Abstract][Full Text] [Related]
14. Dietary flavonoids as intracellular substrates for an erythrocyte trans-plasma membrane oxidoreductase activity.
Fiorani M; Accorsi A
Br J Nutr; 2005 Sep; 94(3):338-45. PubMed ID: 16176603
[TBL] [Abstract][Full Text] [Related]
15. Effect of bioflavonoids on vincristine transport across blood-brain barrier.
Mitsunaga Y; Takanaga H; Matsuo H; Naito M; Tsuruo T; Ohtani H; Sawada Y
Eur J Pharmacol; 2000 May; 395(3):193-201. PubMed ID: 10812049
[TBL] [Abstract][Full Text] [Related]
16. Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-gamma by flavonoids in mouse macrophages.
Liang YC; Tsai SH; Tsai DC; Lin-Shiau SY; Lin JK
FEBS Lett; 2001 May; 496(1):12-8. PubMed ID: 11343698
[TBL] [Abstract][Full Text] [Related]
17. Role of cyclo-oxygenase pathways in the stimulatory influence of immune challenge on the transcription of a specific CRF receptor subtype in the rat brain.
Lacroix S; Rivest S
J Chem Neuroanat; 1996 Feb; 10(1):53-71. PubMed ID: 8703364
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms underlying the protective effects of myricetin and quercetin following oxygen-glucose deprivation-induced cell swelling and the reduction in glutamate uptake in glial cells.
Panickar KS; Anderson RA
Neuroscience; 2011 Jun; 183():1-14. PubMed ID: 21496478
[TBL] [Abstract][Full Text] [Related]
19. Flavonoids inhibit estrogen binding to rat alpha-fetoprotein.
Baker ME; Medlock KL; Sheehan DM
Proc Soc Exp Biol Med; 1998 Mar; 217(3):317-21. PubMed ID: 9492341
[TBL] [Abstract][Full Text] [Related]
20. Role of quercetin on hepatic urea production in acute renal failure.
Nikolić J; Cvetković T; Sokolović D
Ren Fail; 2003 Mar; 25(2):149-55. PubMed ID: 12739822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
